发明名称 |
COMPOSITION FOR SOLID PHARMACEUTICAL PREPARATION OF SOLIFENACIN OR SALT THEREOF |
摘要 |
A solid pharmaceutical preparation of solifenacin or a salt thereof, the preparation being stable and inhibited from decomposing with time when supplied to clinical fields. In a pharmaceutical preparation containing solifenacin or a salt thereof, the compound in an amorphous form was revealed to be causative of cardinal-drug decomposition with time. The composition for a solid pharmaceutical preparation of solifenacin or a salt thereof contains solifenacin or its salt each in a crystalline from, and the content provided are: a process for producing the composition; and a medicinal composition for solid pharmaceutical preparations which contains solifenacin and an amorphization inhibitor. |
申请公布号 |
KR20120030597(A) |
申请公布日期 |
2012.03.28 |
申请号 |
KR20127004903 |
申请日期 |
2005.03.24 |
申请人 |
ASTELLAS PHARMA INC. |
发明人 |
SUGIHARA AKIO;YASUJI TAKEHIKO;MASAKI KATSUHIRO;MURAYAMA DAISUKE |
分类号 |
C07D453/02;A61K9/20;A61K31/439;A61K47/34;A61P1/12;A61P13/02;A61P27/08;C07D215/20 |
主分类号 |
C07D453/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|